Damiles, Hannah Jane .

HRN: 06-26-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
CEFUROXIME 1.5GM (VIAL)
05/06/2025
05/07/2025
IVT
1.5g
Q8 X 3 Doses
S/p CS
Waiting Final Action 
05/06/2025
CEFUROXIME 500MG (TAB)
05/06/2025
05/13/2025
PO
500 Mg
BID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: